Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2542432rdf:typepubmed:Citationlld:pubmed
pubmed-article:2542432lifeskim:mentionsumls-concept:C0042338lld:lifeskim
pubmed-article:2542432lifeskim:mentionsumls-concept:C0042769lld:lifeskim
pubmed-article:2542432lifeskim:mentionsumls-concept:C0011900lld:lifeskim
pubmed-article:2542432lifeskim:mentionsumls-concept:C0086231lld:lifeskim
pubmed-article:2542432lifeskim:mentionsumls-concept:C2745888lld:lifeskim
pubmed-article:2542432lifeskim:mentionsumls-concept:C0205473lld:lifeskim
pubmed-article:2542432lifeskim:mentionsumls-concept:C1704788lld:lifeskim
pubmed-article:2542432pubmed:issue3lld:pubmed
pubmed-article:2542432pubmed:dateCreated1989-7-5lld:pubmed
pubmed-article:2542432pubmed:abstractTextThe levels of Varicella-zoster virus (VZV)-specific IgG, IgM, and IgA antibodies produced in 22 cases of varicella, 22 cases of cutaneous zoster, and 12 cases of acute aseptic meningitis due to VZV in the absence of cutaneous lesions, were measured by indirect enzyme immunoassay (EIA) and compared with those observed in a group of 34 age-matched controls. The definition of cutoff titres for each serological marker and combinations of them allowed early diagnosis of infection in 82% of varicella patients and 91% of patients with acute aseptic meningitis lacking cutaneous lesions on a single serum sample, the specificity being over 90%. The system was as sensitive as the demonstration of intrathecally produced IgG antibodies for the early diagnosis of the infection in 22 cases of neurological disease due to VZV. A working protocol for the serological diagnosis of VZV infections, using currently available EIA reagents, is described.lld:pubmed
pubmed-article:2542432pubmed:languageenglld:pubmed
pubmed-article:2542432pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2542432pubmed:citationSubsetIMlld:pubmed
pubmed-article:2542432pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2542432pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2542432pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2542432pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2542432pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2542432pubmed:statusMEDLINElld:pubmed
pubmed-article:2542432pubmed:monthMarlld:pubmed
pubmed-article:2542432pubmed:issn0146-6615lld:pubmed
pubmed-article:2542432pubmed:authorpubmed-author:EchevarríaJ...lld:pubmed
pubmed-article:2542432pubmed:authorpubmed-author:LeónPPlld:pubmed
pubmed-article:2542432pubmed:authorpubmed-author:de OryFFlld:pubmed
pubmed-article:2542432pubmed:authorpubmed-author:TéllezAAlld:pubmed
pubmed-article:2542432pubmed:issnTypePrintlld:pubmed
pubmed-article:2542432pubmed:volume27lld:pubmed
pubmed-article:2542432pubmed:ownerNLMlld:pubmed
pubmed-article:2542432pubmed:authorsCompleteYlld:pubmed
pubmed-article:2542432pubmed:pagination224-30lld:pubmed
pubmed-article:2542432pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:2542432pubmed:meshHeadingpubmed-meshheading:2542432-...lld:pubmed
pubmed-article:2542432pubmed:meshHeadingpubmed-meshheading:2542432-...lld:pubmed
pubmed-article:2542432pubmed:meshHeadingpubmed-meshheading:2542432-...lld:pubmed
pubmed-article:2542432pubmed:meshHeadingpubmed-meshheading:2542432-...lld:pubmed
pubmed-article:2542432pubmed:meshHeadingpubmed-meshheading:2542432-...lld:pubmed
pubmed-article:2542432pubmed:meshHeadingpubmed-meshheading:2542432-...lld:pubmed
pubmed-article:2542432pubmed:meshHeadingpubmed-meshheading:2542432-...lld:pubmed
pubmed-article:2542432pubmed:meshHeadingpubmed-meshheading:2542432-...lld:pubmed
pubmed-article:2542432pubmed:meshHeadingpubmed-meshheading:2542432-...lld:pubmed
pubmed-article:2542432pubmed:meshHeadingpubmed-meshheading:2542432-...lld:pubmed
pubmed-article:2542432pubmed:meshHeadingpubmed-meshheading:2542432-...lld:pubmed
pubmed-article:2542432pubmed:meshHeadingpubmed-meshheading:2542432-...lld:pubmed
pubmed-article:2542432pubmed:meshHeadingpubmed-meshheading:2542432-...lld:pubmed
pubmed-article:2542432pubmed:meshHeadingpubmed-meshheading:2542432-...lld:pubmed
pubmed-article:2542432pubmed:meshHeadingpubmed-meshheading:2542432-...lld:pubmed
pubmed-article:2542432pubmed:meshHeadingpubmed-meshheading:2542432-...lld:pubmed
pubmed-article:2542432pubmed:meshHeadingpubmed-meshheading:2542432-...lld:pubmed
pubmed-article:2542432pubmed:meshHeadingpubmed-meshheading:2542432-...lld:pubmed
pubmed-article:2542432pubmed:year1989lld:pubmed
pubmed-article:2542432pubmed:articleTitleDefinition of high-proficiency serological markers for diagnosis of varicella-zoster virus infections by enzyme immunoassay.lld:pubmed
pubmed-article:2542432pubmed:affiliationCentro Nacional de Microbiología, Virología e Inmunología Sanitarias, Madrid, Spain.lld:pubmed
pubmed-article:2542432pubmed:publicationTypeJournal Articlelld:pubmed